Literature DB >> 32284191

Seven-Year Follow-up of Gene Therapy for Leber's Hereditary Optic Neuropathy.

Jiajia Yuan1, Yong Zhang2, Hongli Liu1, Dan Wang1, Yangyang Du1, Zhen Tian2, Xin Li2, Shuo Yang3, Han Pei4, Xing Wan4, Su Xiao5, Lin Song1, Xiao Xiao1, Jian Sun1, Zhitao Wang1, Bin Li6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32284191     DOI： 10.1016/j.ophtha.2020.02.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  11 in total

Review 1.  Gene therapy for inherited retinal diseases.

Authors:  Yan Nuzbrokh; Sara D Ragi; Stephen H Tsang
Journal:  Ann Transl Med       Date:  2021-08

2.  Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison.

Authors:  Nancy J Newman; Patrick Yu-Wai-Man; Valerio Carelli; Valerie Biousse; Mark L Moster; Catherine Vignal-Clermont; Robert C Sergott; Thomas Klopstock; Alfredo A Sadun; Jean-François Girmens; Chiara La Morgia; Adam A DeBusk; Neringa Jurkute; Claudia Priglinger; Rustum Karanjia; Constant Josse; Julie Salzmann; François Montestruc; Michel Roux; Magali Taiel; José-Alain Sahel
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

3.  A Typical Case Presentation with Spontaneous Visual Recovery in Patient Diagnosed with Leber Hereditary Optic Neuropathy due to Rare Point Mutation in MT-ND4 Gene (m.11253T>C) and Literature Review.

Authors:  Rasa Liutkeviciene; Agne Sidaraite; Lina Kuliaviene; Brigita Glebauskiene; Neringa Jurkute; Lina Aluzaite-Baranauskiene; Arvydas Gelzinis; Reda Zemaitiene
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

4.  Absence of lenadogene nolparvovec DNA in a brain tumor biopsy from a patient in the REVERSE clinical study, a case report.

Authors:  Nancy J Newman; Matthew Schniederjan; Pia R Mendoza; David J Calkins; Patrick Yu-Wai-Man; Valérie Biousse; Valerio Carelli; Magali Taiel; Francois Rugiero; Pramila Singh; Alexandra Rogue; José-Alain Sahel; Philippe Ancian
Journal:  BMC Neurol       Date:  2022-07-12       Impact factor: 2.903

Review 5.  Clinical Overview of Leber Hereditary Optic Neuropathy.

Authors:  Almina Stramkauskaitė; Ieva Povilaitytė; Brigita Glebauskienė; Rasa Liutkevičienė
Journal:  Acta Med Litu       Date:  2022-06-29

6.  Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene.

Authors:  Yuan Liu; Jeremy D Eastwood; Diego E Alba; Sindhu Velmurugan; Ning Sun; Vittorio Porciatti; Richard K Lee; William W Hauswirth; John Guy; Hong Yu
Journal:  Gene Ther       Date:  2022-04-06       Impact factor: 4.184

Review 7.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

Review 8.  Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.

Authors:  Yan Nuzbrokh; Alexis S Kassotis; Sara D Ragi; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmol Ther       Date:  2020-08-01

9.  Observation of Peripapillary Choroidal Vascularity in Natural Disease Course and After Gene Therapy for Leber's Hereditary Optic Neuropathy.

Authors:  Jingwen Jiang; Gongpeng Sun; Qingmei Miao; Bin Li; Dan Wang; Jiajia Yuan; Changzheng Chen
Journal:  Front Med (Lausanne)       Date:  2021-12-07

10.  Natural history of patients with Leber hereditary optic neuropathy-results from the REALITY study.

Authors:  Patrick Yu-Wai-Man; Nancy J Newman; Valerio Carelli; Chiara La Morgia; Valérie Biousse; Francesco M Bandello; Catherine Vignal Clermont; Lorena Castillo Campillo; Stephanie Leruez; Mark L Moster; Dean M Cestari; Rod Foroozan; Alfredo Sadun; Rustum Karanjia; Neringa Jurkute; Laure Blouin; Magali Taiel; José-Alain Sahel
Journal:  Eye (Lond)       Date:  2021-04-28       Impact factor: 3.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.